ad image

Phase II Trial

1 / 1
Hovione
Ophthalmology

Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction

Hovione

PR-M03-21-003Mar 17, 2021
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
Proof-of-Concept Trial

Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

PR-M11-20-014Nov 18, 2020
Theravance Biopharma, Inc.
Study Results

Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress

Theravance Biopharma, Inc.

PR-M03-19-NI-078Mar 27, 2019
ImaginAb
Oncology

ImaginAb Enrolls First Patient in Phase II Clinical Trial

ImaginAb

PR-M01-19-NI-066Jan 23, 2019
Eisai
Study Results

Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer's Disease

Eisai

PR-M07-18-NI-103Jul 31, 2018
1 / 1